Oman vs Seychelles: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Oman
99.0%
in 2025
Seychelles
99.0%
in 2025
Oman rank
1st
Seychelles rank
1st
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Oman
- Seychelles
How they compare
Oman currently reports 99.0% against 99.0% in Seychelles, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Seychelles ahead.
Oman ranks 1st and Seychelles ranks 1st of 194 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Seychelles | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.0% | 0.0% | 48.0% | Oman |
| 2010s | 98.8% | 10.8% | 88.0% | Oman |
| 2020s | 98.7% | 95.8% | 2.8% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Oman or Seychelles?
- Oman, at 99.0% against 99.0% in Seychelles as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Oman and Seychelles?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Seychelles?
- 18 years are reported by both, from 2008 to 2025.
- How do Oman and Seychelles rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Oman ranks 1st and Seychelles ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.